fda compounding semaglutide enforcement october 2025 is moving to restrict mass-marketed compounded GLP-1 products that aren't FDA-approved, warning companies they can't market them as equivalent to approved drugs and signaling stronger to protect patients from unverified GLP-1 Medications – FDA Guidance

Some of the most serious health problems associated with Ozempic use include: Frequent and prolonged vomiting for more than two weeks Stomach paralysis (gastroparesis) Intestinal blockage (ileus) Bowel obstruction Pancreatitis Kidney damage Thyroid cancer We will explore these Ozempic complications in more detail below

Tirzepatide is an investigational medication

About two-thirds of them had less liver swelling

In Phase 2 trial data, the most commonly reported adverse effects included: Nausea (reported in a significant proportion of participants, particularly during dose escalation) Vomiting Diarrhoea Constipation Decreased appetite (which, whilst contributing to weight loss, can occasionally be excessive) These effects were generally described as mild to moderate in severity and tended to diminish over time as the body adjusted to the medication

While this anxiety can be hard to shake, it can actually aggravate symptoms